Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2022 on February 8, 2023

Conference Call Scheduled for Wednesday, February 8 at 4:30 p.m. Eastern Time SAN DIEGO, Feb. 1, 2023 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine…

Click here to view original post